US FDA device center Director Jeffrey Shuren has issued a new statement on duodenoscope risks, saying the agency continues to receive reports of unacceptable contamination rates, and plans additional actions to reduce patient exposures.
“While our recent actions to stop patient infections have yielded improvements, we also received reports of three deaths of US patients in 2018 related to infections associated with duodenoscopes. That’s...